Hippo Diagnostics

Hippo Diagnostics

Autonomous and efficient allergy diagnostics with simultaneous testing and digital documentation.

HQ location
Heist-op-den-Berg, Belgium
Launch date
Employees
Enterprise value
$19—29m
Company register number
0748.949.371
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

€0.0

round
investor

€0.0

round
investor investor

€0.0

round
*

€4.4m

Early VC
Total Funding000k
Notes (0)
More about Hippo Diagnostics
Made with AI
Edit

Hippo Dx specializes in developing cutting-edge medical devices for the diagnosis of allergies and airway diseases. Founded by Senne Gorris, an ear, nose, and throat surgeon, the company leverages its deep medical expertise and a complementary team to create innovative solutions that streamline the diagnostic process. Hippo Dx's flagship product is an automated skin prick test device that reduces intra-subject variability compared to manual tests, offering reliable, cost-efficient, and time-saving diagnostics. The device can perform 12 simultaneous pricks and provides digital documentation, making it a valuable tool for both physicians and patients. The company operates in the medical device market and primarily serves healthcare providers and clinics specializing in allergy and airway disease diagnostics. Hippo Dx generates revenue through the sale of its diagnostic devices and related services.

Keywords: automated diagnostics, allergy testing, airway diseases, medical devices, digital documentation, simultaneous testing, cost-efficient, reliable, time-saving, healthcare providers.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads